Ticker Details
OraSure Technologies, Inc. OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
IPO Date:	March 17, 1992
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$248.54M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 2.30%
Avg Daily Range (30 D):	$0.07 | 2.36%
Avg Daily Range (90 D):	$0.08 | 2.63%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.45M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	122
Avg Trade Size (Sh.) (90 D):	122

Institutional Trades
Total Institutional Trades:	1,974
Avg Institutional Trade:	$1.26M
Avg Institutional Trade (30 D):	$.63M
Avg Institutional Trade (90 D):	$.76M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.24M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$.84M
Avg Closing Volume:	134.4K

News

May 6, 2026 @ 10:27 PM OraSure (OSUR) Q1 2026 Earnings Transcript Source: Motley Fool Transcribing

Apr 17, 2026 @ 12:10 AM OraSure Technologies Appoints John D. Bertrand to ... Source: Na

Apr 3, 2026 @ 7:15 AM Drug Screening Market Trends 2026–2031: Chr... Source: Mordor Intelligence

Feb 3, 2026 @ 1:00 PM OTC/DTC Infectious Disease Diagnostics Research Re... Source: Researchandmarkets.Com

Jan 15, 2026 @ 6:00 PM OraSure Technologies Confirms Receipt of Director ... Source: Orasure Technologies, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.04	$-.32	$-.27
Diluted EPS	$-1.04	$-.32	$-.27
Revenue	$113.02M	$27.93M	$26.76M
Gross Profit	$47.7M	$11.8M	$10.97M
Net Income / Loss	$-75.07M	$-22.38M	$-19.29M
Operating Income / Loss	$-77.49M	$-23.27M	$-20.1M
Cost of Revenue	$65.31M	$16.12M	$15.8M
Net Cash Flow	$-73.55M	$-21.09M	$-18.53M
PE Ratio